Concepedia

John Raycraft

JR

Statistics

Publications

3

Citations

871

H-Index

3

Active since

2003

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

John Raycraft is an author at Icahn School of Medicine at Mount Sinai specializing in life sciences, oncology, and tumor proteomics.

Publications per year

2003–2006

3

Publications

3

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter et al. · PubMed · 2003 · 719 citations

, , +17

Mesothelin Variant 1 Is Released from Tumor Cells as a Diagnostic Marker

Ingegerd Hellström, John Raycraft, Sandra Kanan et al. · Cancer Epidemiology Biomarkers & Prevention · 2006 · 108 citations · Full text

, , +12

Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137

Shilin Yang, Yi Yang, John Raycraft et al. · Proceedings of the National Academy of Sciences · 2004 · 44 citations · Full text

, , +17

1–3 of 3